Repaglinide Tablet
Product Images NDC 62135-946

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 62135-946). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Repaglinide Tabs 0pt5mg 90s Bottle Label)

Repaglinide Tablets USP 0.5 mg oral tablets label from Chartwell RX, LLC. The label indicates 90 tablets per bottle, prescription only. It includes storage instructions and warnings, a barcode, and states that the tablets have no varnish.*

FDA Label Image

"image Description" (Repaglinide Tabs 1mg 90s Bottle Label)

Repaglinide Tablets USP 1 mg oral tablets packaging label from Chartwell Rx. The label indicates the product contains 90 tablets, is prescription only, and includes storage instructions and warnings. The label features a red and blue design with NDC 62135-947-90 and barcode.*

FDA Label Image

"image Description" (Repaglinide Tabs 2mg 90s Bottle Label)

Repaglinide 2 mg tablets, USP oral medication bottle label from Chartwell RX, LLC. The label indicates prescription use only with a quantity of 90 tablets. Storage and handling instructions are included, along with a barcode and NDC number 62135-948-90.*

FDA Label Image

"image Description" (Repaglinide Tabs Fig 1)

Line graph depicting change in HbA1c percentage over 24 treatment weeks for Repaglinide, Pioglitazone, and their combination. The x-axis shows treatment weeks, and the y-axis shows percentage change in HbA1c. Repaglinide plus Pioglitazone shows the greatest decrease over time compared to either drug alone.*

FDA Label Image

"image Description" (Repaglinide Tabs Structure)

Chemical structure of repaglinide, showing its molecular arrangement with aromatic rings, carbon chains, and functional groups characteristic of this oral antidiabetic drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.